178 related articles for article (PubMed ID: 30086379)
1. Proposal of patient-specific growth plate cartilage xenograft model for FGFR3 chondrodysplasia.
Kimura T; Ozaki T; Fujita K; Yamashita A; Morioka M; Ozono K; Tsumaki N
Osteoarthritis Cartilage; 2018 Nov; 26(11):1551-1561. PubMed ID: 30086379
[TBL] [Abstract][Full Text] [Related]
2. Suppressing UPR-dependent overactivation of FGFR3 signaling ameliorates SLC26A2-deficient chondrodysplasias.
Zheng C; Lin X; Xu X; Wang C; Zhou J; Gao B; Fan J; Lu W; Hu Y; Jie Q; Luo Z; Yang L
EBioMedicine; 2019 Feb; 40():695-709. PubMed ID: 30685387
[TBL] [Abstract][Full Text] [Related]
3. Constitutively-active FGFR3 disrupts primary cilium length and IFT20 trafficking in various chondrocyte models of achondroplasia.
Martin L; Kaci N; Estibals V; Goudin N; Garfa-Traore M; Benoist-Lasselin C; Dambroise E; Legeai-Mallet L
Hum Mol Genet; 2018 Jan; 27(1):1-13. PubMed ID: 29040558
[TBL] [Abstract][Full Text] [Related]
4. Signalling by fibroblast growth factor receptor 3 and parathyroid hormone-related peptide coordinate cartilage and bone development.
Amizuka N; Davidson D; Liu H; Valverde-Franco G; Chai S; Maeda T; Ozawa H; Hammond V; Ornitz DM; Goltzman D; Henderson JE
Bone; 2004 Jan; 34(1):13-25. PubMed ID: 14751559
[TBL] [Abstract][Full Text] [Related]
5. Disruption of a Sox9-β-catenin circuit by mutant Fgfr3 in thanatophoric dysplasia type II.
Shung CY; Ota S; Zhou ZQ; Keene DR; Hurlin PJ
Hum Mol Genet; 2012 Nov; 21(21):4628-44. PubMed ID: 22843502
[TBL] [Abstract][Full Text] [Related]
6. Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias.
Foldynova-Trantirkova S; Wilcox WR; Krejci P
Hum Mutat; 2012 Jan; 33(1):29-41. PubMed ID: 22045636
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias.
Legeai-Mallet L; Benoist-Lasselin C; Munnich A; Bonaventure J
Bone; 2004 Jan; 34(1):26-36. PubMed ID: 14751560
[TBL] [Abstract][Full Text] [Related]
8. Cartilage-specific ablation of XBP1 signaling in mouse results in a chondrodysplasia characterized by reduced chondrocyte proliferation and delayed cartilage maturation and mineralization.
Cameron TL; Gresshoff IL; Bell KM; Piróg KA; Sampurno L; Hartley CL; Sanford EM; Wilson R; Ermann J; Boot-Handford RP; Glimcher LH; Briggs MD; Bateman JF
Osteoarthritis Cartilage; 2015 Apr; 23(4):661-70. PubMed ID: 25600960
[TBL] [Abstract][Full Text] [Related]
9. A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors.
Li C; Chen L; Iwata T; Kitagawa M; Fu XY; Deng CX
Hum Mol Genet; 1999 Jan; 8(1):35-44. PubMed ID: 9887329
[TBL] [Abstract][Full Text] [Related]
10. A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse model.
Jonquoy A; Mugniery E; Benoist-Lasselin C; Kaci N; Le Corre L; Barbault F; Girard AL; Le Merrer Y; Busca P; Schibler L; Munnich A; Legeai-Mallet L
Hum Mol Genet; 2012 Feb; 21(4):841-51. PubMed ID: 22072392
[TBL] [Abstract][Full Text] [Related]
11. Statins do not inhibit the FGFR signaling in chondrocytes.
Fafilek B; Hampl M; Ricankova N; Vesela I; Balek L; Kunova Bosakova M; Gudernova I; Varecha M; Buchtova M; Krejci P
Osteoarthritis Cartilage; 2017 Sep; 25(9):1522-1530. PubMed ID: 28583899
[TBL] [Abstract][Full Text] [Related]
12. New insight on FGFR3-related chondrodysplasias molecular physiopathology revealed by human chondrocyte gene expression profiling.
Schibler L; Gibbs L; Benoist-Lasselin C; Decraene C; Martinovic J; Loget P; Delezoide AL; Gonzales M; Munnich A; Jais JP; Legeai-Mallet L
PLoS One; 2009 Oct; 4(10):e7633. PubMed ID: 19898608
[TBL] [Abstract][Full Text] [Related]
13. An activating Fgfr3 mutation affects trabecular bone formation via a paracrine mechanism during growth.
Mugniery E; Dacquin R; Marty C; Benoist-Lasselin C; de Vernejoul MC; Jurdic P; Munnich A; Geoffroy V; Legeai-Mallet L
Hum Mol Genet; 2012 Jun; 21(11):2503-13. PubMed ID: 22367969
[TBL] [Abstract][Full Text] [Related]
14. Defective proteoglycan sulfation of the growth plate zones causes reduced chondrocyte proliferation via an altered Indian hedgehog signalling.
Gualeni B; Facchini M; De Leonardis F; Tenni R; Cetta G; Viola M; Passi A; Superti-Furga A; Forlino A; Rossi A
Matrix Biol; 2010 Jul; 29(6):453-60. PubMed ID: 20470884
[TBL] [Abstract][Full Text] [Related]
15. HDAC6 deficiency or inhibition blocks FGFR3 accumulation and improves bone growth in a model of achondroplasia.
Ota S; Zhou ZQ; Romero MP; Yang G; Hurlin PJ
Hum Mol Genet; 2016 Oct; 25(19):4227-4243. PubMed ID: 27506979
[TBL] [Abstract][Full Text] [Related]
16. Achondroplasia: Development, pathogenesis, and therapy.
Ornitz DM; Legeai-Mallet L
Dev Dyn; 2017 Apr; 246(4):291-309. PubMed ID: 27987249
[TBL] [Abstract][Full Text] [Related]
17. Perlecan is essential for cartilage and cephalic development.
Arikawa-Hirasawa E; Watanabe H; Takami H; Hassell JR; Yamada Y
Nat Genet; 1999 Nov; 23(3):354-8. PubMed ID: 10545953
[TBL] [Abstract][Full Text] [Related]
18. Altered chondrocyte differentiation, matrix mineralization and MEK-Erk1/2 signaling in an INPPL1 catalytic knock-out mouse model of opsismodysplasia.
Vande Catsyne CA; Sayyed SA; Molina-Ortiz P; Moes B; Communi D; Muller J; Heusschen R; Caers J; Azzi A; Erneux C; Schurmans S
Adv Biol Regul; 2020 May; 76():100651. PubMed ID: 31519471
[TBL] [Abstract][Full Text] [Related]
19. Dmp1-deficient mice display severe defects in cartilage formation responsible for a chondrodysplasia-like phenotype.
Ye L; Mishina Y; Chen D; Huang H; Dallas SL; Dallas MR; Sivakumar P; Kunieda T; Tsutsui TW; Boskey A; Bonewald LF; Feng JQ
J Biol Chem; 2005 Feb; 280(7):6197-203. PubMed ID: 15590631
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical examination of epiphyseal growth plates of Japanese Brown cattle with chondrodysplasia.
Soeta S; Shimoura H; Hatakeyama N; Kodaka T; Amasaki H; Yamano S; Taniguchi K; Naito Y
J Comp Pathol; 2007; 136(2-3):145-55. PubMed ID: 17416234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
